New biological and radiological markers in amyotrophic lateral sclerosis;Nouveaux marqueurs biologiques et radiologiques de la sclérose latérale amyotrophique

Presse Medicale

Volumn 38, Issue 12, 2009, Pages 1843-1851

  Pradat, Pierre François ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COPPER ZINC SUPEROXIDE DISMUTASE; DNA BINDING PROTEIN; MYELIN PROTEIN; PROTEIN NOGO; PROTEIN TDP-43; SUPEROXIDE DISMUTASE; TAR DNA BINDING PROTEIN; UBIQUITIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOPSY; BRAIN; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; GENETIC MARKER; GENETICS; HUMAN; MOTONEURON; NEUROLOGIC EXAMINATION; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SKELETAL MUSCLE; SPINAL CORD;

AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; BIOPSY; BRAIN; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; DNA-BINDING PROTEINS; GENETIC MARKERS; HUMANS; MOTOR NEURONS; MUSCLE, SKELETAL; MYELIN PROTEINS; NEUROLOGIC EXAMINATION; SENSITIVITY AND SPECIFICITY; SPINAL CORD; SUPEROXIDE DISMUTASE; UBIQUITINS;

EID: 73449119288     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2009.01.022     Document Type: Short Survey

References (33)

1. Pradat P.F., Bruneteau G. Quels sont les critères cliniques de la sclérose latérale amyotrophique en fonction des formes cliniques?. Rev Neurol (Paris) 2006, 162(Sp2). 4S29-33.
2. Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N Engl J Med 2001, 344:1688-1700.
3. Forman M.S., Trojanowski J.Q., Lee V.M. TDP-43: a novel neurodegenerative proteinopathy. Curr Opin Neurobiol 2007, 17:548-555.
4. Pradat P.F., Bruneteau G. Quels sont les signes cliniques, classiques et inhabituels, devant faire évoquer une sclérose latérale amyotrophique?. Rev Neurol (Paris) 2006, 162(Sp2). 4S17-24.
5. Chio A., Mora G., Leone M., Mazzini L., Cocito D., Giordana M.T., et al. Early symptom progression rate is related to ALS outcome: A prospective population-based study. Neurology 2002, 59:99-103.
6. Traynor B.J., Codd M.B., Corr B., Forde C., Frost E., Hardiman O.M. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. Arch Neurol 2000, 57:1171-1176.
7. Zoccolella S., Beghi E., Palagano G., Fraddosio A., Samarelli V., Lamberti P., et al. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study. J Neurol Sci 2006, 250(1-2):45-49.
8. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande V.C., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008, 40:572-574.
9. Jokic N., Gonzalez de Aguilar J.L., Dimou L., Lin S., Fergani A., Ruegg M.A., et al. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep 2006, 7:1162-1167.
10. Dupuis L., Gonzalez de Aguilar J.L., Di Scala F., Rene F., de Tapia M., Pradat P.F., et al. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol Dis 2002, 10:358-365.
11. Pradat P.F., Bruneteau G., Gonzalez de Aguilar J.L., Dupuis L., Jokic N., Salachas F., et al. Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes. Ann Neurol 2007, 62:15-20.
12. Jokic N., Gonzalez de Aguilar J.L., Pradat P.F., Dupuis L., Echaniz-Laguna A., Muller A., et al. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol 2005, 57:553-556.
13. Pasinetti G.M., Ungar L.H., Lange D.J., Yemul S., Deng H., Yuan X., et al. Identification of potential CSF biomarkers in ALS. Neurology 2006, 66:1218-1222.
14. Gonzalez de Aguilar J.L., Niederhauser-Wiederkehr C., Halter B., De Tapia M., Di Scala F., Demougin P., et al. Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol Genomics 2008, 32:207-218.
15. Pradat P.F., Bruneteau G. Quels sont les diagnostics différentiels et les formes frontières de SLA?. Rev Neurol (Paris) 2006, 162(Sp2). 4S81-90.
16. Oba H., Araki T., Ohtomo K., Monzawa S., Uchiyama G., Koizumi K., et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993, 189:843-846.
17. Cheung G., Gawel M.J., Cooper P.W., Farb R.I., Ang L.C., Gawal M.J. Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Radiology 1995, 194:263-270.
18. Ngai S., Tang Y.M., Du L., Stuckey S. Hyperintensity of the precentral gyral subcortical white matter and hypointensity of the precentral gyrus on fluid-attenuated inversion recovery: variation with age and implications for the diagnosis of amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2007, 28:250-254.
19. Suhy J., Miller R.G., Rule R., Schuff N., Licht J., Dronsky V., et al. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology 2002, 58:773-779.
20. Kalra S., Hanstock C.C., Martin W.R., Allen P.S., Johnston W.S. Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. Arch Neurol 2006, 63(8):1144-1148.
21. Ellis C.M., Simmons A., Jones D.K., Bland J., Dawson J.M., Horsfield M.A., et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999, 53:1051-1058.
22. Sach M., Winkler G., Glauche V., Liepert J., Heimbach B., Koch M.A., et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004, 127:340-350.
23. Valsasina P., Agosta F., Benedetti B., Caputo D., Perini M., Salvi F., et al. Diffusion anisotropy of the cervical cord is strictly associated with disability in ALS. J Neurol Neurosurg Psychiatry 2007, 28:480-484.
24. Ciccarelli O., Behrens T.E., Altmann D.R., Orrell R.W., Howard R.S., Johansen-Berg H., et al. Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis. Brain 2006, 129:1859-1871.
25. Thivard L., Pradat P.F., Lehericy S., Lacomblez L., Dormont D., Chiras J., et al. Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability. J Neurol Neurosurg Psychiatry 2007, 78:889-892.
26. Grosskreutz J., Kaufmann J., Fradrich J., Dengler R., Heinze H.J., Peschel T. Widespread sensorimotor and frontal cortical atrophy in amyotrophic lateral sclerosis. BMC Neurol 2006, 6:17.
27. Graham J.M., Papadakis N., Evans J., Widjaja E., Romanowski C.A., Paley M.N., et al. Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 2004, 63:2111-2119.
28. Habert M.O., Lacomblez L., Maksud P., El Fakhri G., Pradat J.F., Meininger V. Brain perfusion imaging in amyotrophic lateral sclerosis: extent of cortical changes according to the severity and topography of motor impairment. Amyotroph Lateral Scler 2007, 8:9-15.
29. Hatazawa J., Brooks R.A., Dalakas M.C., Mansi L., Di Chiro G. Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study. J Comput Assist Tomogr 1988, 12:630-636.
30. Turner M.R., Rabiner E.A., Hammers A., al Chalabi A., Grasby P.M., Shaw C.E., et al. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain 2005, 128:896-905.
31. Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C., Shaw C.E., Brooks D.J., et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 2004, 15:601-609.
32. Kew J.J., Leigh P.N., Playford E.D., Passingham R.E., Goldstein L.H., Frackowiak R.S., et al. Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain 1993, 116:655-680.
33. Konrad C., Henningsen H., Bremer J., Mock B., Deppe M., Buchinger C., et al. Pattern of cortical reorganization in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Exp Brain Res 2002, 143:51-56.